Tokyo Tape
Sign in
← Kirin Holdings

Quarterly report · Q1

2503.TEDINET S100TE18
Period2024-01-01 → 2024-03-31
Filed2024-05-13
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥501.8bn2024-01-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥2.13T2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥450.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Operating income¥30.8bn2024-01-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥11.0bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥44.2bn2024-01-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥197.0bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥20.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥25.9bn2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥112.7bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥5.6bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥32.6bn2024-01-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥11.3bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥3.00Tat 2024-03-31Cons.Assets IFRS
Total assets¥2.87Tat 2023-12-31Cons.Assets IFRS
Total assets¥2.47Tat 2023-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.55Tat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥1.44Tat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥1.46Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥1.43Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥1.23Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥1.25Tat 2022-12-31dCons.Equity IFRS
Equity (owners)¥1.16Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.13Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥971.9bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥151.2bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥131.4bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥116.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥88.1bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥39.9bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥203.2bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥41.9bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥65.3bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥226.1bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥31.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥34.7bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥35.9bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥8.6bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥31.982024-01-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥139.162023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥6.92023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥31.982024-01-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥139.152023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥6.92023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio38.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio39.5%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio39.4%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-03-31¥20.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-03-31¥4.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-03-31¥15.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-03-31−¥158m
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-03-31−¥17.2bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-03-31−¥17.2bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-03-31−¥12.3bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-03-31¥238.6bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-03-31¥238.2bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥379m
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-03-31¥18.4bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue2024-01-01 → 2024-03-31¥32.7bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue external2024-01-01 → 2024-03-31¥31.9bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥726m
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentsegment profit2024-01-01 → 2024-03-31−¥1.7bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-03-31¥122.2bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-03-31¥121.5bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥645m
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-03-31¥12.2bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-03-31¥105.6bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-03-31¥105.5bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2024-01-01 → 2024-03-31¥67m
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-03-31¥16.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥22.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥6.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥16.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥265m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥18.0bn
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥18.0bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31−¥11.5bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue2023-01-01 → 2023-03-31¥225.4bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥300m
jpcrp040300-q1r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2023-01-01 → 2023-03-31¥20.9bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue2023-01-01 → 2023-03-31¥18.4bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue external2023-01-01 → 2023-03-31¥17.4bn
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥991m
jpcrp040300-q1r_E00395-000Health Sciencereportable segmentsegment profit2023-01-01 → 2023-03-31−¥1.4bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2023-01-01 → 2023-03-31¥108.6bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2023-01-01 → 2023-03-31¥108.0bn
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥609m
jpcrp040300-q1r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2023-01-01 → 2023-03-31¥9.6bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥93.5bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥93.4bn
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥107m
jpcrp040300-q1r_E00395-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥16.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 779
ItemContextValueUnit
Disposal of treasury shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember0JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Disposal of treasury shares ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Change in scope of consolidation ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Change in scope of consolidation ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Change in scope of consolidation ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Change in scope of consolidation ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Change in scope of consolidation ss IFRSPrior1YTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Change in scope of consolidation ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Share based payment transactions ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Share based payment transactions ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember63000000JPY
Share based payment transactions ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Share based payment transactions ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Share based payment transactions ss IFRSPrior1YTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Share based payment transactions ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-4673000000JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1YTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-1293000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-184000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember1476000000JPY
Total transactions with owners IFRSPrior1YTDDuration_ShareCapitalIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-4610000000JPY
Total transactions with owners IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-30851000000JPY
Total transactions with owners IFRSPrior1YTDDuration_TreasurySharesIFRSMember-4000000JPY
Total transactions with owners IFRSPrior1YTDDuration_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-184000000JPY
Total transactions with owners IFRSPrior1YTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember1476000000JPY
Equity IFRSPrior1QuarterInstant_ShareCapitalIFRSMember102046000000JPY
Equity IFRSPrior1QuarterInstant_CapitalSurplusIFRSMember20909000000JPY
Equity IFRSPrior1QuarterInstant_RetainedEarningsIFRSMember1038562000000JPY
Equity IFRSPrior1QuarterInstant_TreasurySharesIFRSMember-251792000000JPY
Equity IFRSPrior1QuarterInstant_NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember19311000000JPY
Equity IFRSPrior1QuarterInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Equity IFRSPrior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember24585000000JPY
Equity IFRSPrior2YearInstant_EffectivePortionOfCashFlowHedgesIFRSMember-988000000JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember40423000000JPY
Equity IFRSPrior2YearInstant_EquityAttributableToOwnersOfParentIFRSMember980022000000JPY
Equity IFRSPrior2YearInstant_NonControllingInterestsIFRSMember273181000000JPY
Equity IFRSPrior2YearInstant1253203000000JPY
Profit loss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Profit loss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember5591000000JPY
Profit loss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember5736000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass